Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling

被引:34
作者
Oh, You-Take [1 ,2 ]
Yue, Ping [1 ,2 ]
Wang, Dongsheng [1 ,2 ]
Tong, Jing-Shan [3 ,4 ]
Chen, Zhuo G. [1 ,2 ]
Khuri, Fadlo R. [1 ,2 ]
Sun, Shi-Yong [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Winship Canc Inst, Atlanta, GA USA
[3] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
关键词
death receptor 5; invasion; metastasis; caspase-8; TRAF2; TRAIL-R; PROGNOSTIC VALUE; APOPTOSIS; EXPRESSION; MUTATIONS; PROGRESSION; PATHWAY; GENE; DEFICIENCY; TRAF2;
D O I
10.18632/oncotarget.5847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of death receptor 5 (DR5), a well-known cell surface pro-apoptotic protein, in the negative regulation of invasion and metastasis of human cancer cells and the underlying mechanisms are largely unknown and were hence the focus of this study. In this report, we have demonstrated that DR5 functions to suppress invasion and metastasis of human cancer cells, as evidenced by enhanced cancer cell invasion and metastasis upon genetic suppression of DR5 either by gene knockdown or knockout. When DR5 is suppressed, FADD and caspase-8 may recruit and stabilize TRAF2 to form a metastasis and invasion signaling complex, resulting in activation of ERK and JNK/AP-1 signaling that mediate the elevation and activation of matrix metalloproteinase-1 (MMP1) and eventual promotion of cancer invasion and metastasis. Our findings thus highlight a novel non-apoptotic function of DR5 as a suppressor of human cancer cell invasion and metastasis and suggest a basic working model elucidating the underlying biology.
引用
收藏
页码:41324 / 41338
页数:15
相关论文
共 41 条
[1]  
[Anonymous], UROLOGY
[2]   Targeting the extrinsic apoptosis pathway in cancer [J].
Ashkenazi, Avi .
CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (3-4) :325-331
[3]   Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding [J].
Bin, Lianghua ;
Thorburn, Jacqueline ;
Thomas, Lance R. ;
Clark, Peter E. ;
Humphreys, Robin ;
Thorburn, Andrew .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) :28189-28194
[4]   The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer [J].
Duiker, Evelien W. ;
van der Zee, Ate G. J. ;
de Graeff, Pauline ;
Boersma-van Ek, Wytsle ;
Hollema, Harry ;
de Bock, Geertruida H. ;
de Jong, Steven ;
de Vries, Elisabeth G. E. .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :549-555
[5]   Metastasis: recent discoveries and novel treatment strategies [J].
Eccles, Suzanne A. ;
Welch, Danny R. .
LANCET, 2007, 369 (9574) :1742-1757
[6]   Modulation of death receptors by cancer therapeutic agents [J].
Elrod, Heath A. ;
Sun, Shi-Yong .
CANCER BIOLOGY & THERAPY, 2008, 7 (02) :163-173
[7]   Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact [J].
Elrod, Heath A. ;
Fan, Songqing ;
Muller, Susan ;
Chen, Georgia Z. ;
Pan, Lin ;
Tighiouart, Mourad ;
Shin, Dong M. ;
Khuri, Fadlo R. ;
Sun, Shi-Yong .
PLOS ONE, 2010, 5 (08)
[8]   Novel noncatalytic role for caspase-8 in promoting Src-mediated adhesion and Erk signaling in neuroblastoma cells [J].
Finlay, Darren ;
Vuori, Kristiina .
CANCER RESEARCH, 2007, 67 (24) :11704-11711
[9]   TRAU-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis [J].
Finnberg, Niklas ;
Klein-Szanto, Andres J. P. ;
El-Deiry, Wafik S. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :111-123
[10]   Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer [J].
Ganten, Tom M. ;
Sykora, Jaromir ;
Koschny, Ronald ;
Batke, Emanuela ;
Aulmann, Sebastian ;
Mansmann, Ulrich ;
Stremmel, Wolfgang ;
Sinn, Hans-Peter ;
Walczak, Henning .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (10) :995-1007